meRfi®-GM
Hepatocellular Carcinoma (HCC)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Coffee consumption has been shown to decrease the risk of Hepatocellular Carcinoma (HCC) in patients with chronic liver disease
Hepatocellular Carcinoma (HCC) represents the fourth most common cause of cancer-related death.
Programmed cell death protein 1 (PD-1) / CD279, PD-L1 , and cytotoxic T lymphocyte associated protein 4 (CTLA-4) are proteins involved in the modulation of Immune responses , which are u…
References (Sources)
- Application of cancer-testis antigens in immunotherapy of hepatocellular carcinoma (HCC)
- Hepatocellular Carcinoma — Origins and Outcomes
- Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma
- Immunotherapy of Hepatocellular Carcinoma
- Molecular classification of hepatocellular carcinoma: The view from metabolic zonation
- Sequestosome 1/p62-related pathways as therapeutic targets in hepatocellular carcinoma
- Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma